Lifecore Biomedical, Inc. (LFCR) Stock

Lifecore Biomedical, Inc. (LFCR) is a Healthcare stock trading at $5.54 (as of 2026-06-18), with a market capitalization of $188.30M and a trailing P/E of -4.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Lifecore Biomedical, Inc. and its subsidiaries operate an integrated contract development and manufacturing organization, producing pharmaceutical-grade sodium hyaluronate and aseptically formulated injectable products, including filled syringes and vials, and providing development and validation services for clinical and commercial supply. Its Curation Foods segment processes, markets, and sells olive oils, wine vinegars, and guacamole/avocado products under company brands and private labels.

Valuation — source: SEC EDGAR (first-party)
Price	$5.54
Market Cap	$188.30M
P/E Ratio	-4.4
EV / EBITDA	-36.5
Price / Book	-7.31
Price / Sales	1.61
DCF Value (model)	$-1.70
DCF Upside vs Price	-130.7%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$75.52M
Net Margin	-23.8%
Return on Equity	136.1%
Debt / Equity	-5.26
Current Ratio	3.79
Revenue Growth (YoY)	20.0%
EPS Growth (YoY)	-49.1%

Financial Health — source: SEC EDGAR
Altman Z-Score	-0.22 (distress)
Piotroski F-Score	3/9 (weak)

Valuation vs Sector & Industry
Stock P/E	-4.4
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-120.9%
vs Industry	-125.6%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	22NW, LP ($18.87M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Ryan D. Lake
Employees	524
Country	US
IPO Date	1996-02-15

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.